REPOCH compared with RCHOP for the treatment of diffuse large B-cell lymphoma of activated B-cell type

Authors

Phillip Martinez-Knouse, Advocate Aurora HealthFollow
Edward Nabrinsky, Advocate Aurora HealthFollow
Anjana Chandran, Advocate Aurora HealthFollow
Timothy Lestingi, Advocate Aurora HealthFollow
Jacob Bitran, Advocate Aurora HealthFollow

Recommended Citation

Martinez-Knouse P, Nabrinsky E, Chandran A, Lestingi T, Bitran J. REPOCH compared with RCHOP for the treatment of diffuse large B-cell lymphoma of activated B-cell type. Journal of Clinical Oncology. 2020; 38(15S):e20081. doi: 10.1200/JCO.2020.38.15_suppl.e20081

Affiliations

Advocate Lutheran General Hospital

Document Type

Abstract